feed,title,long_url,short_url
Benzinga,"Director at Alaunos Therapeutics Acquires Company Stock Options Worth 100,000 Shares",https://benzinga.com/news/23/06/32797440/director-at-alaunos-therapeutics-acquires-company-stock-options-worth-100-000-shares,https://da.gd/uDiC5C
Benzinga,Alaunos Therapeutics Director Awarded $46K Worth of Stock Options,https://benzinga.com/news/23/06/32797415/alaunos-therapeutics-director-awarded-46k-worth-of-stock-options,https://da.gd/zMfcS
Benzinga,"Board Member at Pliant Therapeutics Acquires Company Stock Options Worth 14,000 Shares",https://benzinga.com/news/23/06/32797414/board-member-at-pliant-therapeutics-acquires-company-stock-options-worth-14-000-shares,https://da.gd/AJJUi
Benzinga,Aerovate Therapeutics Director Awarded $206K Worth of Stock Options,https://benzinga.com/news/23/06/32797412/aerovate-therapeutics-director-awarded-206k-worth-of-stock-options,https://da.gd/seOPj
Benzinga,Reneo Pharmaceuticals Director Awarded $157K Worth of Stock Options,https://benzinga.com/news/23/06/32797406/reneo-pharmaceuticals-director-awarded-157k-worth-of-stock-options,https://da.gd/m8fIV
Benzinga,"Board Member at CARISMA Therapeutics Acquires Company Stock Options Worth 38,700 Shares",https://benzinga.com/news/23/06/32797328/board-member-at-carisma-therapeutics-acquires-company-stock-options-worth-38-700-shares,https://da.gd/EeCeWA
Benzinga,CARISMA Therapeutics Director Awarded $239K Worth of Stock Options,https://benzinga.com/news/23/06/32797318/carisma-therapeutics-director-awarded-239k-worth-of-stock-options,https://da.gd/MIKz
Benzinga,CARISMA Therapeutics Chief Financial Officer Awarded $1.47M Worth of Stock Options,https://benzinga.com/news/23/06/32797314/carisma-therapeutics-chief-financial-officer-awarded-1-47m-worth-of-stock-options,https://da.gd/XgQlC
Benzinga,CARISMA Therapeutics Board Member Awarded $239K Worth of Stock Options,https://benzinga.com/news/23/06/32797308/carisma-therapeutics-board-member-awarded-239k-worth-of-stock-options,https://da.gd/jOnjA
Benzinga,"Director at Reneo Pharmaceuticals Acquires Company Stock Options Worth 14,815 Shares",https://benzinga.com/news/23/06/32797305/director-at-reneo-pharmaceuticals-acquires-company-stock-options-worth-14-815-shares,https://da.gd/cx1mh
Benzinga,CARISMA Therapeutics Chief Scientific Officer Awarded $1.47M Worth of Stock Options,https://benzinga.com/news/23/06/32797300/carisma-therapeutics-chief-scientific-officer-awarded-1-47m-worth-of-stock-options,https://da.gd/x46Es
Benzinga,Reneo Pharmaceuticals Board Member Awarded $157K Worth of Stock Options,https://benzinga.com/news/23/06/32797294/reneo-pharmaceuticals-board-member-awarded-157k-worth-of-stock-options,https://da.gd/7PG1GW
Benzinga,Reneo Pharmaceuticals Executive Chairman Awarded $157K Worth of Stock Options,https://benzinga.com/news/23/06/32797284/reneo-pharmaceuticals-executive-chairman-awarded-157k-worth-of-stock-options,https://da.gd/840U1
Benzinga,"President and CEO at CARISMA Therapeutics Acquires Company Stock Options Worth 600,000 Shares",https://benzinga.com/news/23/06/32797282/president-and-ceo-at-carisma-therapeutics-acquires-company-stock-options-worth-600-000-shares,https://da.gd/JehoL
Benzinga,Cryptocurrency Quant Falls More Than 3% In 24 hours,https://benzinga.com/markets/cryptocurrency/23/06/32797215/cryptocurrency-quant-falls-more-than-3-in-24-hours,https://da.gd/bmOiAZ
